{"id":616339,"title":"Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T19:32:18.226000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-requirements-conducting-clinical-research-psilocybin.html","snippet":"Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin January 11, 2022 Our file number: 21-121678-792 Health Canada is issuing this notice to…","rawSnapshotUrl":"/api/snapshots/raw/616339","browseUrl":"https://replay.healtharchive.ca/job-6/20260302193218/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-clarification-requirements-conducting-clinical-research-psilocybin.html#ha_snapshot=616339","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}